IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

MC Announces Three-Year CAD$80.4 Million Sales Agreement with Gross Margin of 50% by Focus Medical with Super Pharm, Israel’s Largest Pharmacy Chain, for IMC-Branded Medical Cannabis Products

Focus Medical has entered into a three-year binding sales agreement with Super-Pharm, Israel’s largest pharmacy chain, for 13,575kg of IMC branded medical cannabis products Sales to begin in April 2020 through Super-Pharm’s omnichannel distribution network including...
IMC Announces Sales Agreement Signed by Focus Medical for $71.6 Million in Revenue and Gross Margin of 50%, Now $193.5 Million Under Binding Agreements

IM Cannabis Provides Business Update on COVID-19

Israeli and German operations continue to advance strategic priorities, investments into innovation will be deferred Israeli operation to benefit from two supply agreements and one sales agreement recently signed by Focus Medical IM Cannabis currently has CAD$8...